Intuitive Surgical · Multi-Quarter Financial Trends

16 quarters · As reported by the company · Amounts in USD billions← ISRG

Quarter	Period End	Revenue ($B)	YoY	Gross Margin	Operating Income ($B)	Net Income ($B)	Net Margin	Free Cash Flow ($B)	EPS	Buybacks ($B)	Dividends ($B)
FY2026 Q2	2026-06-30	2.89	+18.5%	67.8%	0.97	0.82	28.3%	1.06	2.29	0.32	—
FY2026 Q1	2026-03-31	2.77	+23.0%	66.1%	0.86	0.82	29.6%	0.91	2.28	1.12	—
FY2025 Q4	2025-12-31	2.87	+18.8%	66.4%	0.86	0.79	27.7%	0.89	2.19	0.20	—
FY2025 Q3	2025-09-30	2.51	+22.9%	66.4%	0.76	0.70	28.1%	0.84	1.95	1.91	0.00
FY2025 Q2	2025-06-30	2.44	+21.4%	66.3%	0.74	0.66	27.0%	0.72	1.81	0.18	—
FY2025 Q1	2025-03-31	2.25	+19.2%	64.7%	0.58	0.70	31.0%	0.58	1.92	0.00	—
FY2024 Q4	2024-12-31	2.41	+25.2%	68.0%	0.73	0.69	28.4%	0.82	1.89	0.00	—
FY2024 Q3	2024-09-30	2.04	+16.9%	67.4%	0.58	0.57	27.7%	0.71	1.56	0.00	0.00
FY2024 Q2	2024-06-30	2.01	+14.5%	68.3%	0.57	0.53	26.2%	0.62	1.46	0.00	—
FY2024 Q1	2024-03-31	1.89	+11.5%	65.9%	0.47	0.54	28.8%	0.27	1.51	0.00	—
FY2023 Q4	2023-12-31	1.93	+16.5%	66.2%	0.45	0.61	31.4%	0.23	1.69	0.07	—
FY2023 Q3	2023-09-30	1.74	+12.0%	66.9%	0.47	0.42	23.8%	0.55	1.16	0.00	0.00
FY2023 Q2	2023-06-30	1.76	—	66.7%	0.46	0.42	24.0%	0.67	1.18	0.00	—
FY2023 Q1	2023-03-31	1.70	—	65.6%	0.39	0.36	20.9%	0.37	1.00	0.35	—
FY2022 Q4	2022-12-31	1.66	—	67.1%	0.37	0.32	19.6%	0.44	0.90	1.00	—
FY2022 Q3	2022-09-30	1.56	—	67.6%	0.40	0.32	20.8%	0.38	0.90	1.00	—

Quarterly figures come from the company's 10-Q and 10-K filings. The fourth quarter is derived as the full year minus the first three quarters; cash flow items are converted from fiscal year-to-date totals into single quarters.